Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Biosimilar developers without PBM private-label arrangements gain market access
Therapeutic synergy between GLP-1RAs and antineoplastic agents The combination of GLP-1RAs with various antineoplastic agents not only demonstrates significant tumor-suppressive effects but also has the potential to augment the clinical outcomes of current treatment regimens
Once in use, storage requirements vary by product: Ozempic (semaglutide): Up to 6 weeks at or below 30C Wegovy (semaglutide): Up to 28 days at or below 30C Trulicity (dulaglutide): Up to 14 days at or below 30C Victoza/Saxenda (liraglutide): Up to 30 days at or below 30C Always consult your specific product's patient information leaflet or pharmacist for guidance, as storage requirements differ between brands
Study populations matter
